Daphne Quimi Buys $9.44K of Amylyx Pharmaceuticals Inc (AMLX) — SEC Form 4, May 16, 2024
Open-Market Net Purchase · SEC Form 4
+$9,436
Equity Position
5K sh
0 → 5,000
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Daphne Quimi CIK 0001543031 |
Director
|
Daphne Quimi at Amylyx Pharmaceuticals Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Amylyx Pharmaceuticals Inc
| 2026-06-08 | Award | — | View |
| 2025-06-09 | Award | — | View |
| 2024-06-07 | Award | — | View |
| 2023-06-12 | Award | — | View |
| 2022-06-10 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2024-05-14 | P - Purchase | 2,750 A | $1.89 | +$5,184 | 2,750 | Direct |
| Common Stock | 2024-05-15 | P - Purchase | 2,250 A | $1.89 | +$4,252 | 5,000 | Direct |
Related filings at Amylyx Pharmaceuticals Inc
Institutional Holders
13F holders · Jun 30, 2026
205
institutional managers reporting a position
Largest by reported value
- Fmr Llc $300M
- Black Rock, Inc. $159M
- Perceptive Advisors Llc $150M
5%+ Holders · 13D/G
5 filers
-
Fmr Llc 15.0%
-
Black Rock, Inc. 7.1%
-
Commodore Capital Lp 5.1%
Other insiders at Amylyx Pharmaceuticals Inc
-
George M Milne Jr -$831K
-
Camille L Bedrosian -$325K
-
James M Frates -$350K
-
Gina Mazzariello -$310K
-
Justin B. Klee -$980K
GET /v1/forms/4/0000950170-24-061294
API docs
View Original SEC Filing